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The syntheses of molecules 1-3 were published previously. S1 For convenience, a description of their syntheses and characterization are given here:
General Notes for Chemical Synthesis
All reagents were purchased at highest commercial quality and used without further purification except where noted. Air-and moisture-sensitive liquids and solutions were transferred via syringe or stainless steel cannula. Organic solutions were concentrated by rotary evaporation below 40 °C at approximately 20 mmHg. All non-aqueous reactions were carried out under anhydrous conditions. Yields refer to chromatographically and spectroscopically ( 1 H NMR, 13 C NMR) homogeneous materials, unless otherwise stated. Reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25 mm Dynamic Adsorbents, Inc. silica gel plates (60F-254) and visualized under UV light and/or developed by dipping in solutions of 10% ethanolic phosphomolybdic acid (PMA) and applying heat. Dynamic Adsorbents, Inc. silica gel (60, particle size 0.040-0.063 mm) was used for flash chromatography. NMR spectra were recorded on the Varian Mercury 400, 300 and/or Unity 500 MHz instruments and calibrated using the residual non-deuterated solvent as an internal reference. The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, b = broad. High resolution mass spectra (HRMS) were recorded on a VG 7070 HS mass spectrometer under electron spray ionization (ESI) or electron impact (EI) conditions. 
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1H), 7.69 (d, J= 8.7 Hz, 1H), 7.55 (dd, J= 1.7, 8.7 Hz, 1H), 7.49 (dd, J= 1.7, 8.5 Hz, 1H) , 4.84 (bs, 2H); 13 C NMR (100 MHz, CDCl 3 ) δ 138. 8, 133.9, 131.7, 129.7, 129.5, 129.5, 127.4, 126.1, 125.2, 119.8, 65 .2.
To a suspension of pyridinium chlorochromate (2.4 g, 11 mmol) in anhydrous CH 2 Cl 2 (60 mL) was added a solution of the above alcohol in anh. CH 2 Cl 2 , and the reaction was heated under reflux for 5 hours. Upon completion, it was cooled to room temperature and poured into diethyl ether. The solution was then filtered through a pad of silica and concentrated under reduced pressure to yield S1 (2.4 g, 95%). S1: white solid; R f = 0.67 (EtOAc: General procedure for the synthesis of 6-amino-substituted naphtaldehydes (S2-S4)
In dry and degassed toluene (0.8 mL), were added Pd(OAc) 2 (0.022 mmol) and P(tBu) 3 (0.078 mmol)
After stirring for 20 min, S1 (0.207 mmol), the appropriate amine (0.249 mmol) and Cs 2 CO 3 (0.280 mmol) were added and the reaction left stirring for three days under reflux. After three days, the reaction was cooled at room temperature, diluted with CH 2 Cl 2 , filtered, concentrated under reduced pressure and purified via silica gel flash chromatography (hexanes/EtOAc 0-10%). 9, 151.9, 138.5, 134.4, 131.3, 130.4, 127.2, 126.3, 123.4, 119.5, 108.8, 49.6, 25.5, 24. 3, 155.4, 151.9, 137.7, 134.7, 130.6, 127.2, 126.4, 125.9, 125.6, 119.2, 116.4, 108.3, 71.8, 70.7, 70.5, 70.5, 68.7, 65.3, 58.9, 49.3, 25.4, 24.3 155.2, 151.3, 137.2, 134.4, 130.6, 127.4, 127.0, 126.1, 126.0, 118.5, 116.1, 108.5, 99.4, 71.8, 70.7, 70.5, 70.4, 68.6, 66.5, 65.3, 58.9, 48 2, 155.4, 151.4, 137.5, 134.5, 130.6, 127.4, 126.9, 126.1, 126.1, 119.0, 116.2, 108.7, 99.3, 71.9, 70.8, 70.6, 70.5, 68.8, 65.4, 59.0, 54.8, 48 
6-(piperidin-1-yl)naphthalene-2-carbaldehyde (S2
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Staining of brain tissue sections
Male and female transgenic mice overexpressing wild type mouse PrP (Tga20) were inoculated with the mouse-adapted prion strain mCWD and were euthanized upon developing terminal signs of prion disease. Transgenic mice (19959) harboring the Aβ plaques express the mutant human amyloid precursor protein 695 APP SweInd , which bears both the Swedish (K670N/M671L) and the Indiana (V717F) mutations, under the control of the Syrian hamster prion protein promoter. S2 Mice were euthanized between 9 -13 months of age. S2 Frozen brain sections from transgenic mice producing Aβ and PrP Sc protein were dried for 1 hr, treated with 100%, 95%, and 70% ethanol for 5 min each, and then rinsed with deionized water.
Sections were then buffered with phosphate-buffered saline (1X PBS) for 30 min. Compounds 1, 2, and 3 were diluted 1:50 in 1X PBS (from stock solutions of 3mM) to a final concentration of 60uM, added to brain sections, incubated for 30 min at room temperature, washed with 1X PBS, and coverslipped using DAKO fluorescent mounting media.
Fluorescence microscopy
Brain tissue samples were excited with a 488 nm laser on an Olympus FluoView FV1000 spectral deconvolution confocal microscope. The emission spectra of compounds 1, 2, and 3 bound to Aβ, PrP Sc , and background were collected in 1 nm increments from 450-650 nm. A minimum of 10 measurements were collected for each compound bound to plaque and non-plaque regions as a background control.
The wavelength corresponding to the maximum relative fluorescence intensity was taken as the emission λ max .
Spectroscopic studies of the ANCA probes versus pH
Each probe was dissolved in 95:5 deionized water:DMSO solution to a final concentration of 200 μM and titrated with 10 mM HCl and 1 M HCl with aliquots removed in approximately pH=0.5 increments starting from basic pH. Aliquots were evaluated on a SpectraMAX 190 absorbance microplate reader (Molecular Devices) in 1 nm increments from 250-550 nm. Fluorescence emission spectra for each aliquot were obtained using a PTI spectrofluorimeter in 1 nm increments from 400-650 nm. Each probe was excited with a wavelength corresponding to the spectral window in which both base probe and protonated probe showed good absorption. Maximum intensity wavelengths were plotted agaisnt pH and fit to a Boltzmann sigmoidal curve to estimate the pK a .
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Fluorescence studies with aggregated Aβ peptides
Aggregated Aβ peptide was prepared as described previously. S3 Briefly, we dissolved Aβ42 in PBS pH 7.4 to a final concentration of 100 µM. This solution was magnetically stirred at 1200 rpm for 3 days at room temperature. Aliquots of 15 µL of the pre-aggregated Aβ42 solution was added to 285 µL of the probe (5% DMSO in nanopure water) to attain a final concentration of 5 µM Aβ42 and 4 µM of the probe. The solution was transferred to a 300 µL cuvette and the fluorescence was measured. Figure S1 . Fluorescence emission spectra of ANCA probes 1-3 in PBS buffer in the presence or absence of aggregated Aβ peptide. Probe 1 was excited at λ max = 410 nm. Probes 2 and 3 were excited at λ max = 400 nm.
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Determination of binding constant
Pre-aggregated Aβ42 (5 µM final concentration) was mixed with various concentrations of probes (10, 5, 2.5, 1.25 µM) in 5% DMSO in nanopure water and their K d 's were determined as described previously. S1 Figure S2 . Plots of the fluorescence intensity versus concentration of probes 1-3 in the presence of aggregated Aβ peptide. The K d was determined as described previously S1 by fitting the data to a onesite specific binding algorithm: Y = B max *X/(K d +X), where X is the concentration of the probe, Y is specific binding fluorescence intensity, and B max corresponds to the apparent maximal observable fluorescence upon binding of probes to aggregated Aβ42 peptide.
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Brightfield color imaging
Brain tissue sections were imaged under an Olympus MVX10 Macroview equipped with a MWB2 (Japan) long-pass filter. Each sample was illuminated with epifluorescence and imaged with an exposure time of 0.2 sec. Congo red samples were imaged with an exposure time of 0.1 sec. Figure S3 . Brightfield true color images of compounds 1, 2, and 3 bound to plaque deposits in brain tissue sections from mice. Scale bar = 100 μm. Aβ plaque deposits shown were located in the hippocampus; PrP Sc deposits were located in the corpus callosum. Fluorescence emission maximas of Aβ and PrP Sc stained plaques for compound 1 were measured at 535 ± 3 nm and 554 ± 2 nm, respectively. For compound 2, Aβ and PrP Sc stained plaques had emission maximas at 525 ± 4 nm and 541 ± 4 nm, respectively. For compound 3, Aβ and PrP Sc stained plaques had emission maximas at 515 ± 4 nm and 538 ± 3 nm, respectively.
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Staining of frozen brain sections with Congo red
Frozen brain sections from transgenic mice with Aβ and PrP Sc plaques were dried for 1 hr, treated with 100%, 95%, and 70% ethanol for 5 min each, and then rinsed with deionized water. Sections were then buffered with a working solution of sodium chloride in 1X PBS for 20 min. A 2% solution of Congo red was prepared in 1X PBS, added to brain sections, incubated for 1 hr at room temperature, washed with deionized water, and coverslipped using DAKO fluorescent mounting media. Figure S4 . Aβ and PrP Sc deposits in brain tissue sections stained with Congo red. Scale bar = 100 μm.
A) Image of Congo red staining in transgenic mice with deposits of Aβ. B) Real-color image of Congo red staining in prion-infected mice. C) Fluorescence emission spectra of stained plaques. The maximum fluorescence was measured at 593 ± 3 nm for Aβ deposits, and at 594 ± 8 nm for PrP Sc deposits. S11 Figure S5 . Plots of the fluorescence emission λ max versus Stokes shift for compounds 1-3 measured in different organic solvents. Each compound was dissolved in solvent to a final concentration of 1.5 μM.
Error bars represent the standard deviation from at least two independent runs. Plots were fit with the linear function: Y = m·X + b. The linear fits are shown in red, and the values for slope and intercept obtained from these fits are given within each graph.
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Solvent studies of probes
Each probe was dissolved in dimethylsufloxide (DMSO), methanol (MeOH), 2-propanol (iPrOH), dichloromethane (DCM), ethyl acetate, chloroform, and toluene to a final concentration of 1.5 μM.
Excitation and fluorescence emission spectra of each solution was obtained on a PTI spectrofluorimeter in 1 nm increments from 350-520 nm and 400-650 nm, respectively. The wavelength corresponding to the maximum intensity was taken as λ max . and ε 0 of the solvent was stronger when the refractive index of the solvent was not considered.
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